VISTAGEN THERAPEUTICS, INC. Professional Fees
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Professional Fees of $345.00 thousand for the 3-month period ending 2020-09-30, per its 10-K filed 2022-06-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2022-06-23
- VISTAGEN THERAPEUTICS, INC. professional fees for the quarter ending 2020-09-30 was $345.00K.
| Period end | Professional Fees 3 month |
|---|---|
| 2020-09-30 | $345.00K 10-K · filed 2022-06-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |